Healeex, a compact wellness device
using innovative hybrid cold plasma technology, is about to conquer a plethora
of applications. WILD is the manufacturing partner for the product.

The approach is innovative. The non-invasive, portable device is a true all-rounder.
The ”best startup of the year“ award at the Med-Tech World Summit in Malta in
2023 and the huge interest it attracted at the Arab Health fair in Dubai in 2024
demonstrate the enormous potential of Healeex. The device was developed by two visionaries, Domagoj Prebeg and Emil Baric’ of Synergotron: ”Our objective is to close gaps in tissue regeneration, pain alleviation and the increasing threat from antibiotic-resistant bacteria.“

HYBRID COLD PLASMA TECHNOLOGY
Armed with expert knowledge in biomedicine, electrical engineering, mechanical engineering and health technology,
the two embarked on developing an innovative hybrid plasma technology, combining it with five additional physical stimuli, including photobiomodulation, magnetic field therapy and electrical stimulation. ”Our control unit allows us to
generate these diverse, precisely calibrated stimuli, which are then precisely transmitted using resonance electrodes. It is exactly this directionality that makes our technology so cutting-edge“, CEO Domagoj Prebeg explains. The result:
studies show that Healeex improves blood circulation, reduces inflammations, and significantly accelerates tissue
regeneration.

VARIETY OF APPLICATIONS
The non-invasive approach of Healeex allows for its use in many different areas ranging from sports medicine to cosmetic industry and veterinary medicine. The product is currently certified as a wellness device. To be able to use it in a clinical environment, Synergotron aims to develop the next generation of the device into a medical product. And this is why Synergotron chose the WILD Group as a manufacturing partner. ”We are currently supporting our customer in the ramp-up
phase by developing an assembly concept and optimising the supply chain. Synergotron chose us because we are capable of quickly scaling up production in the case of higher demand and because we work with established, well-proven serial processes“, explains Franz Aigner, Head of Business Development at the WILD Group. ”We can thus guarantee constant product quality and delivery stability.“